NEW YORK (GenomeWeb) – Canada's Norgen Biotek has signed a supplier agreement with Biodesix to provide sample preparation products.
Under the terms of the agreement, Norgen will supply sample preparation products based on its purification technology. The firm offers kits for DNA, RNA, cell-free DNA and RNA, exosome, and protein extraction as well as a DNA, RNA, and protein all-in-one kit.
"Norgen has a proven track record for best-in-class products for RNA, DNA and protein stabilization and sample preparation, and we are confident that this agreement will foster a long and mutually beneficial relationship between Norgen and Biodesix," Norgen President Yousef Haj-Ahmad said in a statement.
Gary Pestano, Biodesix VP of product development and operations, added that the GeneStrat liquid biopsy already uses Norgen's sample prep products in the assay workflow.
Boulder, Colorado-based Biodesix offers blood-based cancer profiling tests including GeneStrat, a test for EML4-ALK fusions, and VeriStrat, proteomic test for certain non-small cell lung cancer patients. It runs the GeneStrat at its CLIA-certified laboratory.
Last week, Biodesix completed a $22 million Series F financing round.